patients must self-administer a topical antibi-
otic, steroid and nonsteroidal to prevent
infection and treat post-op inflammation and
pain.
"Patients often complain about the complex
post-op drop regimen they must endure," he
adds. "They feel like their eye is healed days
after surgery and wonder why they have to
continue self-administering drops for several
weeks. Any product that reduces the frequen-
cy of drops or simplifies the post-op drop reg-
imen will make the cataract surgery experi-
ence better for patients."
• Omidria from Omeros is a phenylephrine
and ketorolac intraocular irrigating solution
that's administered through balanced saline
solution during surgery and indicated to main-
tain pupil dilation and improve post-op heal-
ing.
"The drug has been proven to reduce the
risk of the most feared complications of
cataract surgery by preventing intraopera-
tive miosis," says Dr. Hovanesian.
Omidria faced an uncertain future when its
"pass-through" status expired on Dec. 31,
2017. CMS grants pass-through status to test
the effectiveness and demand of innovative
drugs and products. In Omidria's case, sur-
gery centers could bill CMS separately for
D E C E M B E R 2 0 1 8 • O U T PA T I E N T S U R G E R Y. N E T • 5 5
9 Orchard, Suite 111
Lake Forest, CA 92630
www.optisurgical.com
info@optisurgical.com
Call AOI for Information
800.576.1266 or
949.580.1266
Instrument Rinse System
®
• For instruments with lumen
and tubing
• Provides consistent rinsing
pressure and volume
regardless of the operator
• Eliminates hand fatigue caused
by repetitive syringe use
• Frees up your hands to perform
other tasks, greatly improving
the speed and efficiency of
your reprocessing department
Still rinsing
with a syringe?
Use the
